Janssen reports positive results from two Phase III trials of guselkumab in plaque psoriasis

Janssen Research& Development has reported positive results from two Phase III clinical trials of guselkumab for the treatment of adults with moderate-to-severe plaque psoriasis.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news